ストックスクリーナーアプリを入手
32.65
0.28%
0.09
アフターアワーズ：
32.85
0.20
+0.61%
前日終値:
$32.56
開ける：
$32.94
24時間の取引高:
4.36M
Relative Volume:
1.00
時価総額：
$3.64B
収益：
-
当期純損益:
$-99.15M
株価収益率:
-35.11
EPS:
-0.93
ネットキャッシュフロー:
$-74.25M
1週間 パフォーマンス:
-16.94%
1か月 パフォーマンス:
-30.09%
6か月 パフォーマンス:
-34.49%
1年 パフォーマンス:
+52.43%
1日の値動き範囲:
$32.56
$34.24
1週間の範囲:
$32.51
$39.40
52週間の値動き範囲:
$20.47
$99.41
Viking Therapeutics Inc Stock (VKTX) Company Profile
名前
Viking Therapeutics Inc
セクター
電話
858-704-4660
住所
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
32.65 | 3.64B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Piper Sandler | Overweight |
| 2024-11-22 | 開始されました | B. Riley Securities | Buy |
| 2024-11-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-09-11 | 開始されました | JP Morgan | Overweight |
| 2024-06-27 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 繰り返されました | Oppenheimer | Outperform |
| 2024-03-07 | 開始されました | Jefferies | Buy |
| 2024-02-28 | 繰り返されました | Oppenheimer | Outperform |
| 2023-05-31 | 再開されました | ROTH MKM | Buy |
| 2023-03-28 | 繰り返されました | Maxim Group | Buy |
| 2023-03-17 | 開始されました | Stifel | Buy |
| 2021-07-29 | 再開されました | BTIG Research | Buy |
| 2021-05-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 開始されました | BMO Capital Markets | Outperform |
| 2020-05-05 | 開始されました | Chardan Capital Markets | Buy |
| 2020-05-01 | 開始されました | BTIG Research | Buy |
| 2019-07-16 | 開始されました | Oppenheimer | Outperform |
| 2019-06-25 | 開始されました | Stifel | Buy |
| 2019-03-29 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 繰り返されました | Maxim Group | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Mkt Perform |
| 2018-12-12 | 開始されました | B. Riley FBR | Buy |
| 2018-11-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-18 | 繰り返されました | Maxim Group | Buy |
| 2018-09-18 | 繰り返されました | Raymond James | Outperform |
| 2018-07-20 | 開始されました | SunTrust | Buy |
| 2018-06-28 | 開始されました | Raymond James | Outperform |
| 2018-06-01 | 繰り返されました | Laidlaw | Buy |
| 2018-05-31 | 繰り返されました | Maxim Group | Buy |
| 2018-03-26 | 再開されました | H.C. Wainwright | Buy |
| 2017-11-28 | 繰り返されました | Maxim Group | Buy |
| 2017-11-21 | 開始されました | ROTH Capital | Buy |
すべてを表示
Viking Therapeutics Inc (VKTX) 最新ニュース
Viking Therapeutics: The Turning Point Is Not Here Yet - Seeking Alpha
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Zacks Investment Research
Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week - MSN
These 10 Firms Were Last Week’s Worst Performers - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.8%Here's Why - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Receives "Buy" Rating from HC Wainwright - MarketBeat
12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - sharewise
Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.8%Here's What Happened - MarketBeat
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL
Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential - MSN
We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks - MSN
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today - Benzinga
NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down - Yahoo Finance
Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock’s a buy. - MSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday - MSN
Viking Therapeutics Becomes Oversold (VKTX) - Nasdaq
Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Viking Therapeutics’ oral-2735 could differentiate asset, says JPMorgan - MSN
International Assets Investment Management LLC Reduces Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics begins VK2735 Phase II trial for obesity treatment - Yahoo Finance
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug - Yahoo Finance
Viking Therapeutics begins phase 2 trial for obesity drug By Investing.com - Investing.com Nigeria
Should You Buy the Dip on This High-Flying Stock? - AOL
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity - The Malaysian Reserve
Viking Therapeutics (NASDAQ:VKTX) Earns "Buy" Rating from HC Wainwright - MarketBeat
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral - GuruFocus.com
Viking Therapeutics begins phase 2 trial for obesity drug - Investing.com
Viking Therapeutics Launches Phase 2 Trial for Oral Weight Loss Drug After Impressive Early Results - StockTitan
Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Viking Therapeutics COO sells $2.3 million in stock By Investing.com - Investing.com South Africa
Viking therapeutics CEO sells $8.3 million in stock - Investing.com India
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 50,309 Shares of Stock - MarketBeat
Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) COO Sells 54,215 Shares of Stock - MarketBeat
Viking therapeutics CEO sells $8.3 million in stock By Investing.com - Investing.com Nigeria
Viking Therapeutics CFO sells shares worth $2.15 million By Investing.com - Investing.com Nigeria
Viking Therapeutics COO sells $2.3 million in stock - Investing.com
VKTXViking Therapeutics, Inc Latest Stock News & Market Updates - StockTitan
President & CEO Lian Brian was granted 256,133 shares and sold $8,313,601 worth of shares (194,490 units at $42.75), increasing direct ownership by 3% to 2,366,570 units (SEC Form 4) - Quantisnow
Chief Operating Officer Mancini Marianna was granted 66,200 shares and sold $2,317,599 worth of shares (54,215 units at $42.75), increasing direct ownership by 3% to 374,134 units (SEC Form 4) - Quantisnow
Chief Financial Officer Zante Greg sold $2,150,595 worth of shares (50,309 units at $42.75) and was granted 66,200 shares, increasing direct ownership by 11% to 165,259 units (SEC Form 4) - Quantisnow
SEC Form 4 filed by Director Macartney Lawson - Quantisnow
1 Under-the-Radar Stock to Buy Before It Soars by 156%, According to Select Wall Street Analysts - The Motley Fool
Higher Biopharma M&A Activity ‘Almost Inevitable’ in 2025, With Viking as Top Candidate: Analysts - BioSpace
SA Asks: Which biotechs are most likely to be acquired near-term? - Seeking Alpha
Why Viking Therapeutics Stock Plummeted by 24% in December - MSN
Viking Therapeutics Inc (VKTX) 財務データ
収益
当期純利益
現金流量
EPS
Viking Therapeutics Inc (VKTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mancini Marianna | Chief Operating Officer |
Jan 06 '25 |
Sale |
42.75 |
54,215 |
2,317,599 |
374,134 |
| ZANTE GREG | Chief Financial Officer |
Jan 06 '25 |
Sale |
42.75 |
50,309 |
2,150,595 |
165,259 |
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):